COMMUNIQUÉS West-GlobeNewswire

Aquinox to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
Scapa Healthcare Starts Construction on New Medical Device Manufacturing Facility in Knoxville, TN
21/03/2018
WINDSOR, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions for advanced wound care, medical device and consumer wellness markets, is [...]
SELLAS Life Sciences Announces Appointment of Barbara A. Wood as Executive Vice President, General Counsel and Corporate Secretary
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral Mucosal Immunotherapy Platform
21/03/2018
New York, March 21, 2018 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a biopharmaceutical company focused on improving treatment options for allergies, announced today that the Japan Patent Office (JPO) has recently [...]
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
21/03/2018
MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]
Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%
21/03/2018
BUENA, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Bespoke Extracts’ Sponsored Sportsbike Racer Robertino Pietri Takes Third Place at 77th Annual Running of the Daytona 200
21/03/2018
SUNNY ISLES, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTC Pink:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, is pleased to announce that in the debut of its [...]
Vectura Group plc: 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products
21/03/2018
Vectura Group plc 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products - Chippenham, UK - 21 March 2018: Vectura Group plc (LSE: VEC) ("Vectura", "the [...]
Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ)
21/03/2018
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Press release Lund on March 21, 2018 Notice of annual [...]
Sun BioPharma Provides Business Update and Files Annual Report for 2017
21/03/2018
Front-Line Combination Study with Gemcitabine and Nab-Paclitaxel to begin patient enrollment early in 2 nd Quarter Raised $1.3M in private financing MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. ( [...]
Achaogen Announces Date of FDA Advisory Committee Meeting for Plazomicin
21/03/2018
-- Meeting planned for May 2, 2018 -- SOUTH SAN FRANCISCO, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials [...]
Avinger Enters into Settlement Agreement for All Outstanding Securities Class Action Litigation
21/03/2018
REDWOOD CITY, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that [...]
BioSyent Releases Results for Fourth Quarter and Full Year 2017
21/03/2018
TORONTO, March 21, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three and twelve months ended December 31, 2017. Key highlights include: [...]
Albireo to Present at 17th Annual Needham & Company Healthcare Conference
21/03/2018
BOSTON, March 21, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
BioSig Technologies Announces Participation in Bates College’s Purposeful Work Initiative
21/03/2018
Santa Monica, CA, March 21, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Incysus to Present at BioCentury Future Leaders Conference
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced today that [...]
Clearside Biomedical to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
ALPHARETTA, Ga., March 21, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Caelum Biosciences Announces Clinical Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 16th International Symposium on Amyloidosis
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ: FBIO ) Company developing treatments for rare and life-threatening diseases, today announced that the [...]
Arch Biopartners Granted Pre-Ind Meeting With FDA for Candidate Drug to Prevent Acute Kidney Injury
21/03/2018
TORONTO, March 21, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB: ACHFF ), announced today that a Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and [...]

Pages